Upstate Active Clinical Trials

Study Title:

ROLE of HTLVS and related endogenous sequences in autoimmune diseases and human cancers

What is the purpose of the study?

We are studying the HTLV/human T-cell leukemia virus-related endogenous sequence, HRES-1. The HRES-1 gene may help to regulate the body's autoimmune response. We are studying the role of this gene in patients with autoimmune diseases (such as lupus, multiple sclerosis) and cancer, their family members and in healthy volunteers. Genes are composed of the genetic material called DNA. DNA (deoxyribonucleic acid) is the part of the cell that is responsible for providing hereditary characteristics (such as eye color) and is used to build proteins. Several genes have been discovered that are associated with autoimmune diseases and cancer. We would like to study your (your child's) DNA to determine whether you have (your child has) an abnormality in these genes, or to find new genes that cause these problems. Participation in this study will involve you (your child) to donate blood.

Upstate Institutional Review Board (IRB) Number:

256524

Study Phase:

N/A

Patient Age Group:

Adults

Principal Investigator:

Andras Perl, MD, PhD

Who is eligible?

Patients and local family members over the age of 18, healthy volunteers over the age of 18, distant family members over the age of 18

What is involved if I participate?

  • How long is the study?
    30 Minutes
  • Is transportation provided or reimbursed?
    Yes
  • Is parking provided or reimbursed?
    Yes
  • What tests and procedures are involved?
    Complete consent form to draw blood and draw blood from the arm

Where will the study take place?

SUNY Upstate Medical University; 750 East Adams Street; 8301 Weiskotten Hall, Syracuse, NY 13210

Who can I contact for more information?

Name: Andras Perl, MD, PhD
Phone: 315-464-4194
Email: perla@upstate.edu

Return to Previous Page || Search Again